↓ Skip to main content

Dove Medical Press

High Expression of Cyclin D1 is an Independent Marker for Favorable Prognosis in Middle Eastern Breast Cancer

Overview of attention for article published in OncoTargets and therapy, May 2021
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (51st percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter
3 X users

Citations

dimensions_citation
7 Dimensions

Readers on

mendeley
15 Mendeley
Title
High Expression of Cyclin D1 is an Independent Marker for Favorable Prognosis in Middle Eastern Breast Cancer
Published in
OncoTargets and therapy, May 2021
DOI 10.2147/ott.s309091
Pubmed ID
Authors

Abdul K Siraj, Sandeep Kumar Parvathareddy, Padmanaban Annaiyappanaidu, Saeeda O Ahmed, Nabil Siraj, Asma Tulbah, Fouad Al-Dayel, Dahish Ajarim, Khawla S Al-Kuraya

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 15 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 15 100%

Demographic breakdown

Readers by professional status Count As %
Librarian 1 7%
Other 1 7%
Student > Doctoral Student 1 7%
Student > Bachelor 1 7%
Student > Ph. D. Student 1 7%
Other 2 13%
Unknown 8 53%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 3 20%
Medicine and Dentistry 2 13%
Social Sciences 2 13%
Immunology and Microbiology 1 7%
Unknown 7 47%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 June 2021.
All research outputs
#15,076,069
of 25,387,668 outputs
Outputs from OncoTargets and therapy
#770
of 3,016 outputs
Outputs of similar age
#220,756
of 453,943 outputs
Outputs of similar age from OncoTargets and therapy
#15
of 101 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. This one is in the 40th percentile – i.e., 40% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,016 research outputs from this source. They receive a mean Attention Score of 2.9. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 453,943 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.
We're also able to compare this research output to 101 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.